FISCAL NOTE
Date Requested: February 27, 2017
Time Requested: 02:44 PM |
| Agency: |
Pharmacy, WV Board of |
|---|
| CBD Number: |
Version: |
Bill Number: |
Resolution Number: |
| 2673 |
Introduced |
HB2653 |
|
|---|
| CBD Subject: |
Crime |
|---|
|
FUND(S):
8537
Sources of Revenue:
Special Fund
Legislation creates:
Neither Program nor Fund
Fiscal Note Summary
Effect this measure will have on costs and revenues of state government.
The NPLEX pseudoephedrine sales tracking database is a nationwide database that is provided for free to the states through funding by the pseudoephedrine manufacturers funneled through the National Association of Drug Diversion Investigators. There is no cost to West Virginia government for this database or access to it. The NPLEX database is incorporated into law in West Virginia Code Chapter 60A, Article 10, with requirements on pharmacies as sellers of pseudoephedrine to use it and report into it. There is no revenue generated by the State from this database.
Fiscal Note Detail
| Effect of Proposal |
Fiscal Year |
2017
Increase/Decrease
(use"-") |
2018
Increase/Decrease
(use"-") |
Fiscal Year
(Upon Full
Implementation) |
| 1. Estmated Total Cost |
0 |
0 |
0 |
| Personal Services |
0 |
0 |
0 |
| Current Expenses |
0 |
0 |
0 |
| Repairs and Alterations |
0 |
0 |
0 |
| Assets |
0 |
0 |
0 |
| Other |
0 |
0 |
0 |
| 2. Estimated Total Revenues |
0 |
0 |
0 |
Explanation of above estimates (including long-range effect):
The NPLEX pseudoephedrine sales tracking database is a nationwide database that is provided for free to the states.
Memorandum
Person submitting Fiscal Note: David E. Potters
Email Address: david.e.potters@wv.gov